Financial Performance - The company's operating revenue for 2020 was approximately ¥495.44 million, a decrease of 1.41% compared to ¥488.57 million in 2019[20]. - Net profit attributable to shareholders was approximately ¥91.21 million, representing a 16.67% increase from ¥78.18 million in 2019[20]. - The net cash flow from operating activities increased significantly to approximately ¥127.94 million, a change of 1,024.87% compared to ¥11.37 million in 2019[22]. - The company's total assets reached approximately ¥1.65 billion, an increase of 55.30% from ¥1.06 billion in 2019[20]. - The net assets attributable to shareholders increased to approximately ¥1.21 billion, reflecting a growth of 43.66% from ¥840.74 million in 2019[22]. - Basic earnings per share for 2020 were ¥0.2421, an increase of 11.46% from ¥0.2172 in 2019[21]. - The company's total revenue for the year was 498,705,000.00 RMB, with a net profit of 110,361,430.76 RMB[80]. - The company achieved operating revenue of RMB 494.44 million, a year-on-year increase of 1.41%, and net profit attributable to shareholders of RMB 91.21 million, up 16.67% compared to the previous year[94]. Research and Development - The company's total R&D investment for 2020 was CNY 110.36 million, a significant increase of 44.11% compared to the previous year[57]. - R&D expenses accounted for 22.28% of total revenue, up by 6.6 percentage points from 15.68% in the previous year[57]. - The company applied for 99 new intellectual property rights during the reporting period, of which 82 were granted, bringing the total to 389 applications and 315 grants[55]. - The company launched 20 new patents and received 6 authorizations, totaling 19 patents and 296 copyrights by the end of 2020[53]. - The company has established a three-tiered scientific research and innovation system, which is a core competitive advantage and reflects its technological advancement[41]. - The company has a research and development team of 939 people, accounting for 61.25% of total employees, with over 98% holding a bachelor's degree or higher[100]. Strategic Focus and Market Position - The company focuses on three strategic directions: smart governance, medical insurance, and intelligent electricity, providing software development and technical services to government departments, medical institutions, and State Grid[32]. - The company’s revenue model is stable, primarily derived from software development, technical services, and system integration for government and medical sectors[34]. - The company has established strategic partnerships with major tech firms like Huawei and Alibaba Cloud to enhance its service offerings in smart governance and healthcare[91]. - The company is committed to ensuring the fairness, security, sustainability, and accessibility of the healthcare insurance system for the public[72]. - The company aims to become a leading "AI + Blockchain" technology service provider in China, focusing on smart governance, healthcare, and intelligent energy sectors[142]. Risk Management - The company has detailed various operational risks and corresponding mitigation measures in the report[4]. - The company emphasizes the importance of investment risk awareness regarding forward-looking statements in the report[6]. - The company faces risks related to core competitiveness due to rapid technological advancements in the software and information technology service industry[104]. - The company faces risks related to rising labor costs, which could negatively impact the gross margin of its software development business[106]. Corporate Governance and Compliance - The company has received a standard unqualified audit report from Da Hua Accounting Firm[8]. - The company has no violations of decision-making procedures for external guarantees[7]. - The company has committed to protecting investor interests and will announce any violations of commitments promptly[171]. - The company will not issue any securities until all adverse effects from unfulfilled commitments are eliminated, including stocks and bonds[166]. - The company will take corrective actions within the regulatory timeframe if commitments are not fulfilled[166]. Investment and Financial Strategy - The company plans to distribute a cash dividend of RMB 1.00 per 10 shares, totaling approximately RMB 40,001,000 for the year 2020[5]. - The company does not plan to increase capital reserves or issue bonus shares for the year 2020[5]. - The company will stabilize its stock price through share buybacks and increases in shareholding by major shareholders and executives if specific conditions are met[161]. - The company has committed to effective measures to enhance the efficiency of raised funds, ensuring compliance with regulations and proper usage of funds[164]. - The company will establish a special account for raised funds and sign a tripartite supervision agreement with banks and sponsors[164]. Technology and Innovation - The company’s research and development efforts have led to breakthroughs in key technologies such as big data, blockchain, cloud computing, and artificial intelligence, enhancing its digital platform capabilities[48]. - The company has developed a core technology that supports the operation of specialized, modular, and horizontally scalable big data aggregation platforms, enhancing data analysis speed and application support[50]. - The company has developed a blockchain-based intelligent and trustworthy transmission platform, aimed at reforming social security supply models and improving public service processes[67]. - The company is focused on improving machine learning algorithms suitable for the healthcare sector, particularly in analyzing large volumes of medical insurance and health data[50]. Social Responsibility and Community Engagement - The company actively participates in social responsibility initiatives, including developing platforms for pandemic information and services for migrant workers[197]. - The company complies with environmental protection laws and has not experienced any environmental pollution incidents during the reporting period[198].

Financial Performance - Operating revenue for the period was CNY 33,648,103.23, representing a decline of 13.65% year-on-year[5] - Net profit attributable to shareholders of the listed company was CNY -7,030,375.12, showing an improvement from CNY -13,882,048.92 in the same period last year[5] - The company reported non-recurring gains of CNY 3,089,484.10 for the period[8] - Basic and diluted earnings per share were both CNY -0.0176, an improvement from CNY -0.0386 in the previous year[5] - The company expects to achieve profitability in the second quarter, as the adverse effects of the COVID-19 pandemic have largely dissipated[13] - The net profit for Q1 2021 was -¥7,030,375.12, an improvement from -¥13,882,048.92 in Q1 2020, indicating a reduction in losses by approximately 49.3%[28] - The total comprehensive income for Q1 2021 was -¥7,030,375.12, compared to -¥13,882,048.92 in Q1 2020, showing a reduction in comprehensive losses by 49.3%[28] Cash Flow - The net cash flow from operating activities improved to CNY -36,895,790.74 from CNY -60,533,603.13 year-on-year[5] - The company's operating cash flow improved, with a net cash flow from operating activities of RMB -36,895,790.74, an improvement from RMB -60,533,603.13 in the same period last year[12] - The company reported a net cash flow from operating activities of -¥36,895,790.74 in Q1 2021, an improvement from -¥60,533,603.13 in Q1 2020[35] - The company received cash from operating activities totaling ¥116,771,474.92 in Q1 2021, up from ¥65,120,710.40 in Q1 2020[35] - The net cash flow from operating activities was negative at CNY -36,411,299.71, an improvement from CNY -58,037,867.69 in the same period last year[38] - The company experienced a net increase in cash and cash equivalents of CNY 415,817,516.88 during the quarter, compared to a decrease of CNY -85,157,580.98 in the previous year[36] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,638,659,909.36, a decrease of 0.75% compared to the end of the previous year[5] - The company's total liabilities decreased to CNY 435,341,173.50 in Q1 2021 from CNY 441,362,550.75 in Q4 2020, reflecting a reduction of approximately 1.5%[23] - The company's equity attributable to shareholders was CNY 1,210,342,006.75, a decrease from CNY 1,215,459,980.00 in the previous quarter[23] - Total assets as of March 31, 2021, were CNY 1,645,683,180.25, slightly down from CNY 1,656,822,530.75 at the end of 2020[23] - The total assets of the company decreased to RMB 1,638,659,909.36 from RMB 1,651,081,394.64, indicating a slight decline in overall asset value[18] Shareholder Information - The total number of shareholders at the end of the reporting period was 8,112[9] - The largest shareholder, Shandong Shanda Capital Management Co., Ltd., held 29.58% of the shares[9] Research and Development - Research and development expenses accounted for 80.77% of operating revenue, an increase of 7.19 percentage points compared to the previous year[6] - The company capitalized research and development expenses, resulting in a 49.54% increase in development expenditures to RMB 14,354,362.51 from RMB 9,599,275.91[12] - Research and development expenses for Q1 2021 were ¥20,863,385.24, down from ¥27,128,137.94 in Q1 2020, reflecting a decrease of 23.1%[30] Operating Costs and Expenses - The company reported a 40.56% decrease in operating costs to RMB 10,674,818.87 from RMB 17,957,683.81, attributed to a lower proportion of hardware and system integration projects[12] - Sales expenses increased by 52.47% to RMB 6,248,937.44 from RMB 4,098,553.09, reflecting the company's ongoing efforts to expand its market presence[12] - The financial expenses for Q1 2021 were -¥501,459.38, a decrease from -¥1,338,776.58 in Q1 2020, indicating a reduction of 62.6%[30] Inventory and Receivables - Accounts receivable rose by 1,496.49% to RMB 29,804,272.60 from RMB 1,866,865.00, primarily due to the receipt of bank acceptance bills from customers[12] - Inventory increased by 183.33% to RMB 68,215,163.53 from RMB 24,076,199.09, mainly due to unaccepted large integrated projects[12] - The company reported a decrease in accounts receivable to CNY 131,234,436.35 from CNY 182,091,880.49 year-over-year[21] Government Subsidies and Deferred Income - The company received government subsidies, leading to a 32.93% increase in deferred income to RMB 64,164,495.22 from RMB 48,269,424.96[12] - Deferred income rose to CNY 64,164,495.22 from CNY 48,269,424.96, marking an increase of about 33%[23]

Financial Performance - Net profit attributable to shareholders of the listed company rose by 191.44% to CNY 1,922,363.71 year-on-year[7] - The diluted earnings per share increased by 188.89% to CNY 0.0052[8] - Net profit increased by 191.44% to ¥1,922,363.71 from ¥659,609.22, attributed to a higher proportion of software development and increased government subsidies[18] - Other income grew by 69.85% to ¥12,337,419.81 from ¥7,263,512.53 due to increased government grants[18] - The company reported a net profit margin of approximately 10.5% for the first three quarters of 2020, down from 11.1% in the same period of 2019[32] - The net profit for Q3 2020 reached CNY 21,404,014.92, an increase of 126.5% from CNY 9,467,160.95 in Q3 2019[36] - The total profit for Q3 2020 was CNY 19,448,523.53, an increase of 79.5% from CNY 10,876,148.78 in Q3 2019[36] - The company reported a basic earnings per share of CNY 4.62 for the third quarter of 2020, reflecting an increase compared to the previous year[37] Revenue and Costs - Operating revenue decreased slightly by 0.26% to CNY 218,530,109.87 compared to the same period last year[7] - Total operating revenue for Q3 2020 was ¥98,664,273.54, a decrease of 1.4% compared to ¥100,047,470.11 in Q3 2019[32] - Total operating costs for Q3 2020 were ¥89,238,390.33, down from ¥94,202,654.10 in Q3 2019, reflecting a cost reduction strategy[32] - The company reported a decrease in operating costs to CNY 42,173,932.51 in Q3 2020 from CNY 54,649,045.72 in Q3 2019, a reduction of 22.9%[36] - Other income for Q3 2020 was CNY 2,915,232.42, compared to CNY 3,628,906.84 in Q3 2019, reflecting a decrease of 19.6%[36] Assets and Liabilities - Total assets increased by 27.22% to CNY 1,352,513,268.82 compared to the end of the previous year[7] - The total liabilities increased to ¥231,534,933.08 in Q3 2020 from ¥219,435,448.87 in Q3 2019, indicating a rise in financial obligations[29] - Total current assets decreased slightly to CNY 651,610,045.71 from CNY 652,206,812.51, a reduction of CNY 596,766.80[47] - Total liabilities increased by CNY 3,541,316.73, reaching CNY 225,965,984.00[48] - The company reported a total of CNY 80,193,470.36 in fixed assets, unchanged from the previous period[47] Cash Flow - The company reported a net cash flow from operating activities of CNY -68,949,277.57, an improvement from CNY -87,409,912.14 in the previous year[7] - Cash flow from operating activities improved to -¥68,949,277.57 from -¥87,409,912.14, reflecting reduced cash payments and increased cash receipts from sales[19] - Cash inflows from financing activities totaled CNY 295,881,200.00 in the first three quarters of 2020, with a net cash flow of CNY 284,505,025.93, contrasting with a net outflow of -CNY 35,912,390.95 in 2019[40] - The ending cash and cash equivalents balance as of the end of the third quarter of 2020 was CNY 101,831,762.21, down from CNY 313,630,189.58 at the end of the same period in 2019[40] Shareholder Information - The number of shareholders reached 10,161, with the top ten shareholders holding a significant portion of shares[12] - The largest shareholder, Shandong Shanda Capital, holds 29.58% of the shares[13] - The equity attributable to shareholders rose to ¥1,125,689,370.66 in Q3 2020, compared to ¥843,868,206.92 in Q3 2019, showing strong growth in shareholder value[29] Research and Development - Research and development expenses accounted for 38.36% of operating income, an increase of 8.35 percentage points[8] - Research and development expenses for Q3 2020 were CNY 23,242,723.24, down from CNY 25,197,594.17 in Q3 2019, reflecting a decrease of 7.7%[36] Future Outlook - The company plans to expand its market presence and invest in new product development to drive future growth[32] - The company plans to continue focusing on expanding its market presence and investing in new technologies to drive future growth[37] Other Financial Metrics - Non-recurring gains and losses amounted to CNY 8,728,188.51 for the current period[11] - Cash and cash equivalents decreased by 73.16% to ¥104,594,528.21 from ¥389,665,635.03 due to reclassification of structured deposits[16] - Accounts receivable increased by 59.60% to ¥9,181,151.28 from ¥5,752,561.87 as a result of receiving customer bank acceptance bills[17] - Prepayments surged by 160.53% to ¥26,322,063.96 from ¥10,103,278.19 primarily due to increased business procurement prepayments[17] - Inventory rose by 101.38% to ¥47,463,734.29 from ¥23,569,390.00 driven by increased purchases and unaccepted large integration projects[17] - Other current assets skyrocketed by 11,399.21% to ¥381,045,272.48 from ¥3,313,666.09 due to the purchase of structured deposits[17]

Financial Performance - The company reported a total revenue of RMB 300 million for the first half of 2020, representing a year-on-year increase of 15%[14]. - The net profit for the same period was RMB 50 million, which is a 10% increase compared to the previous year[14]. - The company's operating revenue for the first half of 2020 was CNY 119,865,836.33, a 0.68% increase compared to CNY 119,061,541.85 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was a loss of CNY 19,025,306.93, representing a year-on-year decline of 169.63%[22]. - The net cash flow from operating activities improved by 35.28%, amounting to a loss of CNY 74,089,558.27, compared to a loss of CNY 114,469,646.48 in the previous year[22]. - The company's total assets decreased by 2.14% to CNY 1,040,449,210.06 from CNY 1,063,162,875.57 at the end of the previous year[21]. - The company's net assets attributable to shareholders decreased by 2.76% to CNY 817,563,800.63 from CNY 840,738,208.30 at the end of the previous year[21]. - The company's cash and cash equivalents decreased by 35.94% compared to the beginning of the period, primarily due to procurement, expense, and construction expenditures[66]. - The company reported a significant increase in accounts payable, which rose by 111.24% to CNY 122.65 million, reflecting pending payments for construction at the R&D base[83]. Research and Development - The company has allocated RMB 20 million for research and development in artificial intelligence technologies for the upcoming fiscal year[14]. - Research and development expenses accounted for 46.22% of operating revenue, an increase of 13.47 percentage points compared to 32.75% in the same period last year[22]. - R&D expenses for the current period amounted to ¥55,399,201.72, representing 46.22% of operating revenue[48]. - The company has developed a technology that enables low-cost, efficient interconnection and information sharing between heterogeneous information systems without requiring system interface openings or manual data entry[41]. - The company has developed four core technology categories: intelligent software development, data intelligence, collaborative control, and trusted transmission, supporting various industry solutions[38]. - The company’s intelligent software development framework allows for automated deployment and agile collaboration, enhancing the reliability of software iterations[38]. - The company has established a three-tiered innovation research and development system covering basic technology research, platform development, and solution innovation[28]. - The company achieved significant advancements in blockchain technology, focusing on security and high throughput, with mechanisms to prevent vulnerabilities such as memory limits and overflow issues[44]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share by the end of 2021[14]. - The company is expanding its market presence in Asia, targeting a 30% increase in market share by the end of the fiscal year[108]. - The company primarily adopts a direct sales model, with various marketing teams established across different regions to promote products and services[32]. - The company announced plans for a strategic acquisition of a competitor, which is expected to enhance its product offerings and increase market competitiveness[108]. - The company emphasizes the importance of risk management strategies in its operational discussions, particularly in light of market volatility[4]. Technology and Innovation - The company has developed six major integrated solutions in areas such as human resources, social security, and medical payment systems, reflecting its strategic expansion in these sectors[29]. - The company’s software production utilizes a DevOps platform for customized software development, ensuring alignment with customer needs and industry trends[31]. - The company has implemented a medical insurance fraud detection method based on outlier analysis, improving real-time detection and accuracy compared to traditional rule-based methods[42]. - The blockchain platform ensures data privacy through multi-party encrypted storage and authorized access, enhancing data security measures[43]. - The company has developed a self-evolving intelligent software development environment, enhancing capabilities for traditional industries[59]. Financial Management and Governance - The board of directors has confirmed that all financial reports are accurate and complete, ensuring transparency for investors[5]. - The company has no plans for profit distribution or capital reserve transfer during this reporting period[6]. - The company will ensure compliance with relevant regulations regarding share transfers and disclosures[97]. - The company will ensure the effective use of raised funds to achieve expected project returns, with a dedicated account for fund management[101]. - The company will enhance internal controls and strengthen fund management to prevent fund misappropriation and improve fund utilization efficiency[103]. Legal and Compliance - The company has no major litigation or arbitration matters during the reporting period, indicating a stable legal environment[111]. - There are no significant related party transactions reported, suggesting a focus on transparency and compliance[113]. - The company has received environmental approval for its software research and development base project, indicating compliance with environmental regulations[118]. Shareholder Information - The company issued 40,010,000 shares in its initial public offering on July 17, 2020, increasing total shares from 36,000,000 to 40,001,000[122]. - The largest shareholder, Shandong Shanda Capital Operation Co., Ltd., holds 118,342,400 shares, representing 32.87% of total shares[125]. - The company’s stock price stabilization measures include share buybacks and increased purchases by major shareholders if necessary[97]. Industry Insights - In 2019, the software and information technology service industry in China achieved a total software business revenue of 717.68 billion yuan, reflecting a year-on-year growth of 15.4%[33]. - The total profit of the software and information technology service industry in China reached 93.62 billion yuan in 2019, with a year-on-year increase of 9.9%[33]. - By 2020, the software and information technology service industry in China is projected to exceed 8 trillion yuan in revenue, with an average annual growth rate of over 13%[34].